Advertisement
NewAmsterdam Pharma N.V. (NAMSW)
NASDAQ: NAMSW
· Real-Time Price · USD
8.48
-0.04 (-0.47%)
At close: Apr 29, 2025, 9:33 AM
-0.47% (1D)
| Bid | 7.92 |
| Market Cap | 1.95B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 8.51 |
| Volume | 400 |
| Avg. Volume (20D) | 2,814 |
| Open | 8.48 |
| Previous Close | 8.52 |
| Day's Range | 8.48 - 8.48 |
| 52-Week Range | 5.45 - 16.75 |
| Beta | -0.00 |
About NAMSW
NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, focuses on improving patient care in populations with metabolic diseases. Its lead investigational candidate, obicetrapib, is a novel, selective inhibitor that targets the Cholesteryl Ester Transfer Protein (CETP), which has been clinically shown to reduce low-density lipoprotein cholesterol (LDL-C) while at the same time substantially increase high-density lipoprotein ...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 10, 2021
Employees 68
Stock Exchange NASDAQ
Ticker Symbol NAMSW